Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: college-on-problems-of-drug-dependence.
fees reported
›
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
32 filings
$540K on those filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
117th Congress
Federal Initiative To Guarantee Health by Targeting Fentanyl Act
8 filingsthrough 2022
H.R. 2366117th CongressSTOP Fentanyl Act of 20218 filingsthrough 2022
H.R. 2405117th CongressStreamlining Research on Controlled Substances Act of 20218 filingsthrough 2022
H.R. 2430117th CongressTemporary Reauthorization of the Emergency Scheduling of Fentanyl Analogues Act8 filingsthrough 2022
S. 339117th CongressFederal Initiative to Guarantee Health by Targeting Fentanyl Act8 filingsthrough 2022
H.R. 1732115th CongressSynthetic Drug Control Act of 20178 filingsthrough 2018
S. 1141118th CongressHALT Fentanyl Act7 filingsthrough 2024
S. 253117th CongressCannabidiol and Marihuana Research Expansion Act7 filingsthrough 2022
H.R. 2935116th CongressStopping Overdoses of Fentanyl Analogues Act7 filingsthrough 2020
S. 1622116th CongressStopping Overdoses of Fentanyl Analogues Act7 filingsthrough 2020
S. 2032116th CongressCannabidiol and Marihuana Research Expansion Act7 filingsthrough 2020
S. 1327115th CongressSITSA Act7 filingsthrough 2018
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Edward Long
Capitol Associates, Inc.
3 filingsthrough 2009
Brian RobinsonVan Scoyoc AssociatesCovered position: LA/Corr,Congresswoman Sheila Jackson Lee2 filingsthrough 2010
Covered positions · 3 of 6 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
